Home/Filings/4/0001127602-24-007734
4//SEC Filing

Witherspoon Charles 4

Accession 0001127602-24-007734

CIK 0000105770other

Filed

Feb 29, 7:00 PM ET

Accepted

Mar 1, 1:07 PM ET

Size

8.1 KB

Accession

0001127602-24-007734

Insider Transaction Report

Form 4
Period: 2024-02-28
Witherspoon Charles
VP & Treasurer
Transactions
  • Exercise/Conversion

    Common Stock

    2024-02-28$102.51/sh+2,019$206,9683,998.091 total
  • Sale

    Common Stock

    2024-02-28$358.62/sh2,019$724,0611,979.091 total
  • Exercise/Conversion

    Stock Options (Right to Buy)

    2024-02-282,019529 total
    Exercise: $102.51From: 2020-02-19Exp: 2029-02-19Stock Options (Right to Buy) (2,019 underlying)
Footnotes (1)
  • [F1]This award vests in four equal annual installments beginning on February 19, 2020.

Issuer

WEST PHARMACEUTICAL SERVICES INC

CIK 0000105770

Entity typeother

Related Parties

1
  • filerCIK 0001731739

Filing Metadata

Form type
4
Filed
Feb 29, 7:00 PM ET
Accepted
Mar 1, 1:07 PM ET
Size
8.1 KB